Skip to content

King Pharmaceuticals KG Increase (Decrease) in Premiums Receivable

Increase (Decrease) in Premiums Receivable at other companies

Arch Capital Group logo
Arch Capital GroupACGL
$820M-13.0%
Everest Group logo
Everest GroupEG
-$92M-159%
SiriusPoint logo
SiriusPointSPNT
$160.4M-14.4%
Skyward Specialty Insurance Group, Inc. logo
Skyward Specialty Insurance Group, Inc.SKWD
$55.64M+56.3%
Selective Insurance Group logo
Selective Insurance GroupSIGI
$48.31M-32.8%
W.R. Berkley logo
W.R. BerkleyWRB
$48.65M+11.0%

Other financials

Income statement

See full
Revenue$10.2M+1,112%
Net income-$7.4M-1,786%
EPS (diluted)-$0.96-586%

Balance sheet

See full
Cash & equivalents$62.2M+1,724%
Total debt$176.7M
Total equity$121.4M+2,773%
Total assets$964.2M

Cash flow

See full
Operating cash flow-$15.1M-1,628%

Valuation

See full
Market cap$70.42M-67.6%
Enterprise value$184.93M-50.0%
P/E1.2×
P/S1.6×-24.3×

Profitability

See full
Net margin131.5%

Returns & leverage

See full
Return on equity90.8%
Debt / equity1.5×

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPremiumsReceivable.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's increase (decrease) in premiums receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is King Pharmaceuticals's increase (decrease) in premiums receivable?
King Pharmaceuticals (KG) reported increase (decrease) in premiums receivable of -$373K in Q1 2026.
What does increase (decrease) in premiums receivable mean?
The net change in premiums owed to the company by policyholders during the reporting period. An increase indicates that more premiums have been billed but not yet collected, which can impact short-term liquidity. This metric is a key indicator of the efficiency of the company's premium collection process and credit risk management.